Neil Fleshner
Director Técnico/Científico/I+D en POINT Biopharma, Inc. (United States) .
Cargos activos de Neil Fleshner
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of Toronto | Corporate Officer/Principal | - | - |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - | |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Director/Miembro de la Junta | 01/09/2019 | - |
Director Técnico/Científico/I+D | 01/01/2020 | - | |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Director/Miembro de la Junta | 01/07/2016 | - |
Director Técnico/Científico/I+D | 01/07/2016 | - |
Historial de carrera de Neil Fleshner
Antiguos cargos conocidos de Neil Fleshner.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
POIT BIOP | Director/Miembro de la Junta | 30/06/2021 | 27/12/2023 |
Director Técnico/Científico/I+D | 30/06/2021 | 27/12/2023 | |
Fundador | 15/04/2020 | 27/12/2023 | |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - | - |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - | - |
Princess Margaret Hospital | Corporate Officer/Principal | - | - |
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Director/Miembro de la Junta | 05/12/2005 | - |
Independent Dir/Board Member | 05/12/2005 | - |
Formación de Neil Fleshner.
University of Toronto | Doctorate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Estadísticas
Internacional
Canadá | 8 |
Estados Unidos | 4 |
Operativa
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
POIT BIOP | Health Technology |
Empresas privadas | 7 |
---|---|
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Transportation |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
Princess Margaret Hospital | |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Health Technology |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Commercial Services |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Health Technology |
- Bolsa de valores
- Insiders
- Neil Fleshner
- Experiencia